The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers.

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy, further complicating big decisions the Trump administration will have to make about how to cover the medications.

List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before the inauguration of President-elect Trump. The Centers for Medicare and Medicaid Services (CMS) had until Feb.

The Biden administration on Friday released the next round of prescription drugs selected for Medicare price negotiations, including Ozempic — the blockbuster diabetes drug that’s also used for weight loss.

Biden commutes sentences for nearly 2,500 non-violent drug offenders convicted on crack cocaine-related charges Bill and Melinda Gates gave their kids a strict ‘middle-class' upbringing, refused to just 'buy them things' with their billions — here's how to set your kids up for success Sound of a meteorite hitting Earth captured for the first time – on a doorbell camera Danielle Collins thanked her haters for paying the bills after Australian Open crowd boos Pete Davidson Asked Lorne Michaels to Fire Him After First ‘SNL' Season;